Hercules Capital, Inc. (HTGC)
| Market Cap | 3.33B |
| Revenue (ttm) | 516.85M +4.5% |
| Net Income | 307.63M -3.5% |
| EPS | 1.75 -12.9% |
| Shares Out | 179.45M |
| PE Ratio | 10.57 |
| Forward PE | 9.22 |
| Dividend | $1.88 (10.15%) |
| Ex-Dividend Date | Nov 12, 2025 |
| Volume | 1,103,578 |
| Open | 18.75 |
| Previous Close | 18.70 |
| Day's Range | 18.51 - 18.80 |
| 52-Week Range | 15.65 - 22.04 |
| Beta | 0.78 |
| Analysts | Buy |
| Price Target | 21.00 (+13.33%) |
| Earnings Date | Feb 12, 2026 |
About HTGC
Hercules Capital, Inc. is a business development company. The firm specializing in providing private equity, venture debt, and growth capital to privately held venture capital-backed companies at all stages of development from mid venture to expansion stage including select publicly listed companies and select special opportunity companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management ... [Read more]
Financial Performance
In 2024, Hercules Capital's revenue was $493.59 million, an increase of 7.15% compared to the previous year's $460.67 million. Earnings were $260.14 million, a decrease of -22.15%.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for HTGC stock is "Buy." The 12-month stock price target is $21.0, which is an increase of 13.33% from the latest price.
News
Hercules Capital: A BDC That Ticks The Boxes For Retirement Income
Most BDCs are exposed to a SOFR-driven dividend normalization process. Yet, Hercules Capital stands out as a rare high-quality exception, which has the necessary tools to preserve its base dividend. I...
Savara Announces Amendment to Hercules Capital Debt Facility Providing up to $75M of Additional Debt Funding Upon U.S. Food and Drug Administration (FDA) Approval of MOLBREEVI*
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the amendment of its loan an...
BDCs: Buying 10% Income The Smart Way
Business development companies offer high yields, but investors must be wary of yield traps and underlying credit risks. Premium BDCs like Main Street Capital, Hercules Capital, and Capital Southwest ...
Hercules Capital: Last Man Standing As Internal BDCs Move To Monthly Dividends
Hercules Capital is rated a buy, supported by robust dividend coverage and record originations as the Fed cuts rates. HTGC maintains a 10% dividend yield, with 104% coverage of the aggregate dividend ...
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
BOSTON & MONTREAL--(BUSINESS WIRE)--enGene Holdings Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today announced that it has entered into an a...
The More These High Yields Drop, The More I Buy
The market is pricing in a crisis that the data simply does not show. A misunderstood corner of credit is flashing rare value signals. The disconnect between headlines and fundamentals is growing fast...
The Income Quintet: 5 Pillars Of Safe High Yield
The Income Quintet - BDCs, Midstream Energy, REITs, Preferred Stocks, and Covered Call ETFs - offers a balanced approach to maximizing yield and income safety. I prioritize quality over raw yield, foc...
The Biggest Bargain And The Most Expensive Lottery Ticket I See In The BDC Space
BDC sector valuations remain depressed, with P/NAV metrics under 1x due to falling rates and credit risk concerns. Dividend sustainability is diverging across BDCs; not all will cut, but the ones with...
The Chart That Answers Your Question About BDC Dividend Cuts
Investors have started to question how sustainable BDC dividends are. A lot of this skepticism is logical and justified by valid reasons. My calculus shows that on average BDCs could cut their dividen...
You Say That Like It's a Bad Thing
Last week, I read an interesting opinion piece about my favorite BDC (business development company). It proclaimed: “Hercules Capital's Growth Era is Over—Durability Remains.
Hercules Capital: Pay The BV Premium And Be Done With It
Hercules Capital (HTGC) commands a 53% book value premium, justified by robust NII growth, low non-accruals, and consistent dividend coverage. HTGC's GAAP NII-to-distribution spread has ensured reliab...
Hercules Capital: Diamond In The Rough
Hercules Capital stands out among BDCs by dominating the venture debt niche, with superior deal flow and a lower cost of capital. HTGC's portfolio is concentrated in sectors with structural upside opt...
Hercules Capital: 1.23x Coverage, Outperforming Tech Peers, Solid Yield
Hercules Capital delivered record investment fundings so far in 2025 as well as record Q3 net investment income while maintaining strong dividend coverage. The BDC's robust origination trajectory and ...
My 3 High-Yield Outliers The Market Is Likely Mispricing
I highlight three undervalued high-yield stocks: Lineage, Conagra Brands, and Hercules Capital, each facing unique headwinds. LINE offers a 6.2% yield, trades below asset replacement cost, and leads c...
A Rare Buying Opportunity: Blue-Chip 11-12% Yields Too Cheap To Ignore
There is a major market disconnect in which there are blue-chip dividend payers offering 11%+ yields right now, despite posting strong fundamentals. I discuss why the market is bearish on these stocks...
Worried About Rate Cuts? 2 BDCs Best Positioned For The Storm
Hercules Capital and Trinity Capital are best positioned among BDCs to sustain base dividends amid possible lower interest rates. Both HTGC and TRIN benefit from strong fundamentals, investment-grade ...
Hercules Capital: Opportunity Knocks On This 11% Yield
Hercules Capital offers a compelling mix of high yield, strong credit quality, and steady growth, making it attractive for income investors. HTGC demonstrated strong results, including record new comm...
Don't Bury BDC Dividends Just Yet
The Fed's dovishness has been the key driver for the BDC sell-off. The idea is that lower interest rates should lead to lower dividends (i.e., BDCs cutting their dividend across the board). While it i...
Hercules Capital: Attractive Growth Following Q3 Earnings (Rating Upgrade)
Hercules Capital (HTGC) is upgraded to a buy as its price approaches the five-year price-to-NAV average, offering attractive entry for long-term investors. HTGC maintains strong fundamentals with robu...
Hercules Capital Announces Upcoming Event for the Financial Community
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, ...
Hercules Capital: Buy American Technology And Earn A 10.4% Dividend Yield For 2026
Hercules Capital is now paying out a double-digit dividend yield following a material pullback of its common shares. The technology-focused BDC recorded third-quarter net investment income of $0.49 pe...
10% Income In Private Credit - My Contrarian Bet On A Mispriced Market
Credit spreads are flashing complacency as too much capital chases too few deals. This creates a tricky situation for the market. Personally, I see tight spreads not as safety but as distortion, as th...
2 BDCs To Sell Before They Cut Their Dividend
BDCs have been clearly out of favor this year. Yet, there are some clear pockets of opportunity, which have started to showcase a nice momentum - just as I outlined in my recent BDC strategic piece. I...
BDC Weekly Review: Private Credit Shorts Are Trying To Squeeze Through The BDC Market
We take a look at the action in business development companies through the fourth week of October and highlight some of the key themes we are watching. The BDC sector rebounds for the second consecuti...
